|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 38/47 | |||
| A61K 39/395 | |||
| A61K 31/573 |
| (11) | Patento numeris | 3186281 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15760604.7 |
| Europos patento paraiškos padavimo data | 2015-08-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/047588 |
| Data | 2015-08-28 |
| (87) | Numeris | WO 2016/033555 |
| Data | 2016-03-03 |
| (30) | Numeris | Data | Šalis |
| 201462043351 P | 2014-08-28 | US |
| (72) |
ROSENGREN, Sanna, US
SHEPARD, H., Michael, US
THOMPSON, Curtis, B., US
|
| (73) |
Halozyme, Inc.,
11388 Sorrento Valley Road, San Diego, CA 92121,
US
|
| (54) | COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR |
| COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR |